Inhibition of the NMDA and AMPA receptor channels by antidepressants and antipsychotics
- PMID: 28167075
- DOI: 10.1016/j.brainres.2017.01.028
Inhibition of the NMDA and AMPA receptor channels by antidepressants and antipsychotics
Abstract
It is known that some antidepressants and antipsychotics directly inhibit NMDA-type ionotropic glutamate receptors. In this study we systematically studied action of seven drugs (Fluoxetine, Citalopram, Desipramine, Amitriptyline, Atomoxetine, Chlorpromazine, and Clozapine) on NMDA receptors and Ca2+-permeable and -impermeable AMPA receptors in rat brain neurons by whole-cell patch-clamp technique. Except for weak effect of fluoxetine, all drugs were virtually inactive against Ca2+-impermeable AMPA receptors. Fluoxetine and desipramine significantly inhibited Ca2+-permeable AMPA receptors (IC50=43±7 and 105±12µM, respectively). Desipramine, atomoxetine and chlorpromazine inhibited NMDA receptors in clinically relevant low micromolar concentrations, while citalopram had only weak effect. All tested medicines have been clustered into two groups by their action on NMDA receptors: desipramine, amitriptyline, chlorpromazine, and atomoxetine display voltage- and magnesium-dependent open channel blocking mechanism. Action of fluoxetine and clozapine was found to be voltage- and magnesium-independent. All voltage-dependent compounds could be trapped in closed NMDA receptor channels. Possible contribution of NMDA receptor inhibition by certain antidepressants and antipsychotics to their analgesic effects in neuropathic pain is discussed.
Keywords: Antidepressants; Inhibition; Ionotropic glutamate receptors; Mechanisms; Neuropathic pain; Patch-clamp.
Copyright © 2017 Elsevier B.V. All rights reserved.
Similar articles
-
Inhibitory effect of antidepressants on the NMDA-evoked [(3)H]noradrenaline release from rat hippocampal slices.Neurochem Int. 2009 Nov;55(6):383-8. doi: 10.1016/j.neuint.2009.04.005. Epub 2009 Apr 22. Neurochem Int. 2009. PMID: 19393275
-
Direct inhibitory effect of fluoxetine on N-methyl-D-aspartate receptors in the central nervous system.Biol Psychiatry. 2007 Dec 1;62(11):1303-9. doi: 10.1016/j.biopsych.2007.04.014. Epub 2007 Jul 20. Biol Psychiatry. 2007. PMID: 17659262
-
Inhibition of N-methyl-D-aspartate receptor function appears to be one of the common actions for antidepressants.J Psychopharmacol. 2006 Sep;20(5):629-35. doi: 10.1177/0269881106059692. Epub 2006 Jan 9. J Psychopharmacol. 2006. PMID: 16401669
-
AMPA receptors in the therapeutic management of depression.CNS Neurol Disord Drug Targets. 2007 Apr;6(2):117-26. doi: 10.2174/187152707780363258. CNS Neurol Disord Drug Targets. 2007. PMID: 17430149 Review.
-
Rapid-acting antidepressants.Adv Pharmacol. 2019;86:47-96. doi: 10.1016/bs.apha.2019.03.002. Epub 2019 Apr 24. Adv Pharmacol. 2019. PMID: 31378256 Review.
Cited by
-
Efficacy and safety of chlorpromazine as an adjuvant therapy for glioblastoma in patients with unmethylated MGMT gene promoter: RACTAC, a phase II multicenter trial.Front Oncol. 2023 Dec 14;13:1320710. doi: 10.3389/fonc.2023.1320710. eCollection 2023. Front Oncol. 2023. PMID: 38162492 Free PMC article.
-
Chlorpromazine affects glioblastoma bioenergetics by interfering with pyruvate kinase M2.Cell Death Dis. 2023 Dec 13;14(12):821. doi: 10.1038/s41419-023-06353-3. Cell Death Dis. 2023. PMID: 38092755 Free PMC article.
-
Mechanisms of NMDA Receptor Inhibition by Sepimostat-Comparison with Nafamostat and Diarylamidine Compounds.Int J Mol Sci. 2023 Oct 27;24(21):15685. doi: 10.3390/ijms242115685. Int J Mol Sci. 2023. PMID: 37958669 Free PMC article.
-
Reply to: "The serotonin theory of depression: a systematic umbrella review of the evidence" published by Moncrieff J, Cooper RE, Stockmann T, Amendola S, Hengartner MP, Horowitz MA in Molecular Psychiatry (2022 Jul 20. doi: 10.1038/s41380-022-01661-0).Mol Psychiatry. 2023 Aug;28(8):3153-3154. doi: 10.1038/s41380-023-02093-0. Epub 2023 Jun 16. Mol Psychiatry. 2023. PMID: 37322062 No abstract available.
-
Neuroimaging glutamatergic mechanisms differentiating antipsychotic treatment-response.Sci Rep. 2023 Jun 2;13(1):8938. doi: 10.1038/s41598-022-26702-0. Sci Rep. 2023. PMID: 37268668 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous